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Abstract
Background: Peptide:MHC cellular microarrays have been proposed to simultaneously characterize multiple Ag-specific
populations of T cells. The practice of studying immune responses to complicated pathogens with this tool demands
extensive knowledge of T cell epitopes and the availability of peptide:MHC complexes for array fabrication as well as a
specialized data analysis approach for result interpretation.
Methodology/Principal Findings: We co-immobilized peptide:DR0401 complexes, anti-CD28, anti-CD11a and cytokine
capture antibodies on the surface of chamber slides to generate a functional array that was able to detect rare Ag-specific T
cell populations from previously primed in vitro T cell cultures. A novel statistical methodology was also developed to
facilitate batch processing of raw array-like data into standardized endpoint scores, which linearly correlated with total Ag-
specific T cell inputs. Applying these methods to analyze Influenza A viral antigen-specific T cell responses, we not only
revealed the most prominent viral epitopes, but also demonstrated the heterogeneity of anti-viral cellular responses in
healthy individuals. Applying these methods to examine the insulin producing beta-cell autoantigen specific T cell
responses, we observed little difference between autoimmune diabetic patients and healthy individuals, suggesting a more
subtle association between diabetes status and peripheral autoreactive T cells.
Conclusions/Significance: The data analysis system is reliable for T cell specificity and functional testing. Peptide:MHC
cellular microarrays can be used to obtain multi-parametric results using limited blood samples in a variety of translational
settings.
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Introduction
As important initiators of adaptive immunity, CD4 T cells
express highly specific T-cell receptors that recognize epitopes
derived from protein antigens in the context of Class II MHC
complexes. In the last decade, epitopes associated with a variety of
infectious diseases, allergies, tumors and autoimmune diseases
have been extensively explored. The advent of the Class II MHC
tetramer and its related applications such as tetramer-guided
epitope mapping have substantially increased the efficiency and
accuracy of the epitope discovery process [1,2]. As adequate
epitope information has been generated, one of the next challenges
is to integrate this knowledge to examine overall cellular immune
responses in relevant disease settings. Undoubtedly, tetramer
technology continues to provide a promising approach for ex vivo
and in vitro Ag-specific T cell analysis. However, technical issues
such as the number of fluorochoromes that are distinguishable by
current flow cytometry technology limit the simultaneous analysis
of multiple antigen specificities. Although the latest peptide:MHC
multi-color tetramer staining protocol managed to examine up to
15 Ag-specific T cell populations [3], most often, the detection is
restricted to one or two epitopes at a time.
Cellular microarrays provide an alternative solution [4,5,6,7,8].
This approach uses a high-precision robot arrayer to spot
peptide:MHC complex onto a glass slide with high density. Much
like artificial antigen presenting cells, the immobilized pepti-
de:MHC activates Ag-specific T cells and triggers cytokine
secretion. By co-immobilizing cytokine capture antibody with
the peptide:MHC complex on the glass surface, the cytokines
secreted by the activated T cells are retained in situ and probed
with fluorescence-conjugated cytokine detection antibody for
quantification. Unlike tetramer staining, which provides superb
single-cell-level characteristics, the aim of peptide:MHC cellular
microarrays is to achieve a high-throughput detection solution.
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number of Ag-specificities for evaluation. The cytokine capture
antibodies, in turn, define the functional parameters that are
measured. By using predetermined spatial coordinates (rather than
a panel of fluorescent tags in the flow cytometry setting), a
multitude of different functional T cell responses can be
distinguished and/or compared in a single assay.
Despite their potential, cellular microarrays are still in their
infancy. Previous studies primarily focused on method develop-
ment using in vitro established Ag-specific T cell lines or primary T
cells obtained from TCR transgenic mice [4,7,8]. Only a single
report addressed the changes of tumor antigen-specific CD8 T cell
responses due to vaccination [5]. In this study, combining
pioneering work with our CD4 T cell epitope identification
knowledge, we designed a protocol for functional peptide:MHC
microarray production and a data analysis system suitable to
evaluate the cytokine responses of primary human CD4 T cells. In
the first application, we examined the IFNgamma response of
human CD4 T cells against 36 Influenza A derived epitopes. The
compiled results provided us with a hierarchy of influenza A
epitope specific T cell responses in the general population. This
type of knowledge may provide insights for vaccine development
in the future. In addition, the subject-by-subject results revealed
similarities and differences in anti-viral responses in different
individuals. This type of knowledge may be useful for risk
prediction or diagnosis in infectious disease related translational
research. In the second application we investigated autoimmune
Type 1 Diabetes related self-antigen specific CD4 T cell responses.
We compared IFNgamma and IL10 responses from T cells from
both diabetic and non-diabetic individuals – a typical cross-
sectional study for comparative purposes. Among 10 epitopes
derived from a panel of putative pancreatic beta-cell self-antigens,
there was no single epitope that distinguished diabetic from non-
diabetic subjects. In addition, the accumulated IFNgamma or
IL10 response was not significantly different between individuals
from the two groups.
Results
Characterization of the peptide:MHC cellular microarray
We used a contact-printing robot to fabricate our cellular
microarray. The pin repeatedly delivered ,12.5 nl/spots of
sample solution onto the glass surface of a chamber slide in a
pre-arranged format (Figure 1A far-left panel), yielding a series of
Figure 1. Characteristics of peptide:MHC cellular microarrays. (A) A part of a freshly fabricated microarray image with magnification of
15.756(left panel), 1006(middle panel) and 2006(right panel). (B) A raw fluorescence image of a 4-supergrid 8612 microarray probed with Cy3-
conjugated anti-Rat-IgG. The absolute fluorescence of all 96 spots for the low-right supergrid was quantified and analyzed for the variance. (C) A
microarray loaded with 6610
6 primary human CD4 T cells. (Left panel, 256 magnification) image taken immediately after 6 hours of incubation;
(middle panel, 2006magnification) image taken after aspirating culture medium; (right panel) image taken after washing the slide with 1xPBS for
three times. The numbers at the low-right corners of middle and right panels indicate cell counts. (D) The box/whisker plots represent cell counts of
20 randomly selected spots before (loose attached) and after (tightly attached) washing procedure.
doi:10.1371/journal.pone.0011355.g001
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For a typical 1-chamber slide, the size ratio of printable surface
(18647 mm) to a single spot was approximately 3,400:1. The
distance between the centers of two adjacent spots was 0.8 mm
(Figure 1A middle panel). The size and amount of proteins
immobilized on the surface was highly uniform, with 0.50% co-
efficient of variation (Figure 1B). The spot size and the cell density
determined the number of cells possibly settling on each spot.
Since only the cells ‘‘settling down’’ on the top of a spot had an
opportunity to be activated, the number of cells ‘‘settling’’ on top
of the spots was theoretically relevant to assay sensitivity. In
practice, when we loaded 6610
6 cells on a 1-chamber slide, the
average number of cells attaching to each individual spot was
8976106 (loose attached) (Figure 1C, left and middle panel;
Figure 1D). Around 519668 cells were firmly attached, even after
two rounds of washing with 1xPBS (tightly attached) (Figure 1C,
right panel and Figure 1D). Given the fact that at least one single
Ag-specific T cell is required to produce cytokine upon activation,
based on the cell number/spot as we counted, the best estimate of
the detection limit for Ag-specific T cells is as low as 0.1–0.2%
among all the cells loaded on the slide. Taken together, by using
this setting, we can easily print an array of 20 rows650 columns in
a 1-chamber slide. With 10 replicates for each peptide:MHC/
cytokine feature, this format allows us to evaluate up to 100
features, simultaneously. The lowest number of Ag-specific T cells
(among those total 6610
6 T cells loaded onto the chamber slide)
required for generating detectable signal range from 6,000 to
12,000. Increasing the total number of cells input improved the
number of cells ‘‘landing’’ on those spots, but it negatively
influenced signal/noise ratio of fluorescence measurements.
Scoring system to normalize Ag-specific cytokine
responses from different experiments
To assess clinical samples using the cellular microarray,
particularly for comparative purposes, a standardized data analysis
system is required to transform original fluorescence measure-
ments into normalized results suitable for inter-/intra-assay
comparison. We designed a 6-step protocol of mathematic/
statistical calculations (Figure 2A): 1) the absolute fluorescence
intensity (AFI) of each spotted area was measured as raw data; 2) a
logarithmic transformation of the raw data was taken; 3) replicates
were grouped and compared with the negative control (replicate
spots of empty Class II MHC); 4) the variances of experimental
replicates and control replicates were compared using an F-test; 5)
based on F-test results, one of two types of 2-tailed non-paired t-
tests was chosen to compare the means of the experimental group
and the control group – a regular t-test for equal variances or a t-
test with Welch’s correction for unequal variances; 6) another
logarithmic transformation was performed to convert the p-value of
the t-test into a more readable score. This analysis system ranks
Ag-specific T cell responses by evaluating the statistical difference
between the experimental group and a ubiquitous negative
reference. In this specialized detection system where no standard
curve was available to normalize the activation level of a T cell
response and the variation of fluorescence signal was high, the
advantage of this data analysis approach was that both the AFI
values and the variances (from either a sample or the negative
control) contributed to the underlying p-values (or 2log[p] scores).
Since all 2log[p] scores were calculated against a common
internal negative control, these scores were independent of the
particular assay and could be directly compared. To further
validate the biological implication of this scoring method, we
compared the cellular microarray results of serially diluted CD4 T
cell lines with IFNgamma production in a parallel control
experiment, in which the same numbers of T cells were seeded
into a 96-well plate coated with peptide:MHC and anti-CD28/
CD11a for the same period of stimulation (Figure 3). We found
that those AFIs had less indicative value to reveal the number of
Ag-specific T cells for the assays from different chamber.
However, the 2log[p] scores were not only correlated with the
input of Ag-specific T cells (Figure 3F), but also correlated with
IFNgamma production (from the control experiment) measured
by conventional ELISA (Figure 3G–I). To facilitate batch data
processing, a coding program based on this 6-step procedure was
created with MS-Excel so that the 2log[p] score for various
peptide:MHC features could be calculated and reported equiva-
lently (Figure 2B).
Using peptide:MHC/IFNgamma microarrays to study
Influenza A specific T cell responses
Our first application of the peptide:MHC cellular microarray
was to study Influenza A specific CD4 T cell responses in
randomly selected HLA-DR0401 (DRA1*0401/DRB1*0401)
subjects. Purified CD4 T cells were stimulated with the trivalent
vaccine in vitro in the presence of autologus antigen presenting cells
to boost Ag-specific T cell frequencies prior to cellular microarray
assays. A total of 36 DR0401-restricted epitopes derived from
hemagglutinin (HA), neuraminidase (NA), nuclear protein (NP),
polymerase B1 (PB1) and M1 matrix protein (MP) were assessed
on a single microarray simultaneously. The overall responses for
all 12 subjects indicated that MP, PB1 and H3HA specific
responses were relatively dominant over other antigens (Figure 4A
and Table 1). Figure 4B summarized the T cell responses from
each subject, revealing highly heterogeneous response profiles
among this study population. Donors 1, 2, 6, 7, 9 and 11 showed
weak responses to this influenza A panel with only a few detectable
responses. Donor 3 had strong MP specific responses, moderate
H3HA and H1HA responses. Donor 4 had strong MP and H3HA
specific responses and moderate responses to H1HA and N2NA.
Donor 5 had strong H3HA, N2NA, NP, PB1 and MP specific
responses. Donor 8 had moderate responses to N2NA, NP and
PB1. Donor 10 had moderate responses to H1HA, N1NA, H3HA
and PB1. Donor 12 had moderate responses to H1HA, N1NA,
H3HA, N2NA and PB1.
Using peptide:MHC cellular microarrays to monitor T cell
responses to beta-cell autoantigens
A second, more challenging application was to compare self-
antigen specific T cell responses in individuals expressing
autoimmune Type 1 Diabetes susceptible Class II HLA-DR0401
haplotypes. We selected 10 epitopes derived from putative beta-
cell self-antigens [9,10,11,12,13,14,15]. Purified CD4 T cells were
stimulated with the candidate peptides in the presence of autologus
antigen presenting cells to boost Ag-specific T cell frequencies
prior the assays. The IFNgamma and the IL10 responses from T
cells specific for the 10 candidate epitopes were investigated at the
same time (Table 2). Like other cross-sectional studies, average
2log[p] scores of T cell responses for T1D patients (n=11) and
non-diabetic individuals (n=12) were compared (Table 3). Only
the GAD65p70-specific IL10 response was significantly different
between the two populations (p=0.0315, Mann-Whitney test).
The non-diabetic group was associated with higher GAD65p70
specific IL10 responses (0.448360.1609) than the T1D group
(0.0490960.04157). However, this difference of GAD65p70-
specific IL10 responses between the two groups could be caused
by chance alone since the p-value was higher than 0.05 after false
discovery rate adjustment. The non-diabetic group was also
Functional T Cell Microarray
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responses (0.581760.1671) in comparison to the diabetic group
(0.197360.1107). However, that difference was not statistically
significant (p=0.0777, Mann-Whitney test). We also examined the
differences of T cell responses in a discontinuous trait fashion using
a 95% confidence limit (p,0.05) to distinguish ambiguous results
from those less ambiguous results. A positive response was defined
as 2log[p]$1.30 (p#0.05, 95% confidence limit), whereas a
negative response was defined as 2log[p],1.30. A majority of
subjects did not elicit any detectable IFNgamma or IL10 responses
(Figure 5A–B). No donor responded to more than 4 epitopes. The
counts of detectable epitope specific responses for each individual
were almost evenly distributed between the diabetic and non-
diabetic groups. For each individual epitope, no significant
difference (Mann-Whitney Test) was detected between these two
groups (Table 4), although there were trends showing that (i)
GAD65p70-specific IFNgamma responses were slightly increased
in T1D group; (ii) GAD65p15 and GAD65p35-specific IL10
responses were slightly increased in the non-diabetic group.
Among all 10 epitopes we studied, GAD65p15 (6/23), PPIp57
(4/23), GAD65p70 (4/23) were associated with the most prevalent
IFNgamma response while DMKp2 (5/22), GAD65p35 (4/23)
and PPIp57 (3/23) were associated with the most prevalent IL10
responses (by examining the counts in Table 4).
Discussion
In this study, we developed a cellular microarray using Class II
MHC protein loaded with antigenic peptides. This method
combines the highly Ag-specific features of tetramer technology
with the advantages of high-throughput measurement offered by
microarray platform. By investigating more epitopes and shifting
the targets from well-established Ag-specific T cell lines to highly
heterogeneous clinical samples, our aim was to adapt, simplify and
standardize this peptide:MHC cellular microarray system for
translational studies.
For assay development, our first emphasis was to use relatively
large size spots to maximize the detection sensitivity even though
this practice inevitably diminished the spotting density. The
dimension of the spotting pins as well as composition and
Figure 3. Correlation between microarray results and Ag-specific T cell inputs. A guide to print one 1065 cellular microarray in one subunit
of a 4-chamber slide (A). Raw fluorescence images and measured Absolute Fluorescence Intensity (AFI) of an array chamber loaded with 100610
3 (B),
50610
3 (C), 20610
3 (D) and 5610
3 (E) of Ag-specific HA306, NAp43 and IGRPp31-specific CD4 T cells. No MPp54-specific T cells were loaded for
assaying. Green fluorescence images on the right of each panel represent Ag-specific cytokine production signals probed by AlexFluor555-
conjugated streptavidin while red fluorescence images on the left of each panel represent non-specific signals probed by Cy5-conjugated anti-Rat
IgG to facilitate the spot identification. Band-pass filters avoided spectral overlap. Only the green fluorescence was measured as AFI and proceeded
for quantification. Correlations between ‘‘2log[p]’’ and corresponding numbers of HA306, NAp43 and IGRPp31 specific CD4 T cells are shown in
panel (F). MPp54 data in (F) represents Ag non-specific signals revealed by corresponding chip assays. Correlations between ‘‘2log[p]’’ and
IFNgamma production for HA306 (G), NAp43 (H) and IGRPp31 (I) are also shown to determine the concordance between two different assays
(microarray assay and ELISA).
doi:10.1371/journal.pone.0011355.g003
Figure 2. Illustration of data analysis. (A) Flow-chart; (B) a datasheet layout for a 8612 cellular microarray assay. The contents in black or red
boxes/ovals are relevant to generating final result highlighted by red arrow in the bar graph. The numeric indicators in the brackets of (A) and (B) are
consistent.
doi:10.1371/journal.pone.0011355.g002
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the spot size. In our system, the concentrations of peptide:MHC
complex and cytokine capture antibody saturated the absorption
capacity of the glass surface. By doing so, the condition provided
maximal stimuli and cytokine capturing ability. The theoretical
detection limit (0.1,0.2%) that we estimated is consistent with
previous discussion by Brown and colleagues [4,16]. In practice,
however, if the cytokine production by the T cells with a certain
Ag-specificity is lower than others, a higher number of responding
T cells is required. The purpose of the cellular microarray is to
determine (or semi-quantify) the presence of Ag-specific T cells
rather than providing an exact frequency. Based on its theoretical
detection limit, the sensitivity of this assay system is lower than
ELISPOT assays and may not be sufficient to detect low frequency
or low avidity T cell responses. However, the system should be
adequate to detect high frequency or high avidity responses.
Second, to answer the call for transparency in data documentation
[17,18], we developed a scoring system based on our understand-
ing of what the system was designed to reveal and what the cellular
microarray system was measuring. This data analysis system
provided a statistical indication of differences between the group of
spots for target epitopes and a baseline. Conceptually, a strong
response would associate with high AFI for all spot replicates and
low variance between replicates, while a weak response would
generate the opposite outcome. This feature would be well
reflected by our scoring system - either increasing the overall AFI
or decreasing the variance within the same group favored a
2log[p] score (or a low p-value).
We then appliedthe cellular microarray system to detect immune
responses against foreign antigens and self-antigens. Very different
results were revealed in these two different types of immunological
settings. For foreign antigens, which normally trigger robust
adaptive responses, the cellular microarray system performed quite
well. Average scores for 17 out of 36 epitopes (47%) were above the
95%confidence limit(p=0.05 or2log[p]=1.30).Among these17
epitopes, MP, PB1 and H3HA specific responses were more
prevalent than others. These more robust Ag-specific responses are
likely due to either repeated vaccination or natural infection. It is
noteworthy that prior to the outbreak of swine-origin H1N1
influenza A virus (S-OIV) pandemic, H3N2 has been the most
Figure 4. Results of using peptide:MHC/IFNgamma microarray to measure 36 different influenza A specific CD4 T cell responses.
(A)The average score for each influenza A peptide (n=12); (B) Individual plot for each DR0401 donor. Dotted lines represent the 2log[p] score
equivalent to 95% confidence limit (p=0.05) to further distinguish ambiguous score (p.0.05) from less ambiguous score (p,0.05).
doi:10.1371/journal.pone.0011355.g004
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Prevalent responses to H3HA not only imply strong antigenicity
of this viral surface antigen, but also broad memory T cell response
in the general population. In addition, MP and PB1 are internal
antigens and the most conserved components among different
strains and evensubtypes. Many types of influenza A strains (H1N1,
H3N2, H5N1) can boost memory responses specific to these
epitopes. The relatively weak H1HA specific responses might
indicate a call for new vaccines for emerging H1N1 threats, such as
the Swine-origin H1N1 outbreak in 2009 [19,20].
In the autoimmune disease setting, the performance of the
cellular microarray system was less impressive. Overall, the
measured microarray responses were weak. Among the list of 10
putative autoantigenic epitopes, only GAD65p70 elicited stronger
IL10 responses in the non-diabetic group than in the diabetic
group. Although that observation is consistent with a previous
notion that self-reactive CD4 T cells in non-diabetic subjects might
confer protection by producing regulatory cytokines such as IL10
while those cells in diabetic groups could not [9], the average
scores (2log[p]=0.448360.1609 for non-T1D group vs.
0.0490960.04157 for T1D group) for both populations were
lower than our 95% confidence limit. Despite being statistically
significant by the Mann-Whitney test, the p-value was higher than
0.05 after false discovery rate adjustment. This indicated that the
Table 1. Summary for Influenza A specific T cell responses.
i.d Peptide Sequence
aMean (n=12)
bRanking
p1 H1HA203 203-NQRALYHTENAYVSVVS-219 1.59 13
p2 H1HA328 328-LRMVTGLRNIPSIQSRG-344 1.61 12
p3 H1HA334 334-LRNIPSIQSRGLFGAIA-350 1.26 18
p4 H1HA392 392-TNKVNSVIEKMNTQFTA-408 1.18 20
p5 H1HA398 398-VIEKMNTQFTAVGKEFN-414 0.85 28
p6 H1HA440 440-ELLVLLENERTLDFHDS-456 1.00 23
p7 N1NA96 96-GWAIYTKDNSIRIGSKG-112 1.16 21
p8 N1NA124 124-CSHLECRTFFLTQGALL-140 0.59 33
p9 N1NA219 219-WKKRILRTQESECVCVN-235 0.57 34
p10 N1NA249 249-GAASYKIFKIEKGKVTK-265 1.32 17
p11 N1NA369 369-KGFEMIWDPNGWTDTDS-385 1.19 19
p12 N1NA416 416-DCIRPCFWVELVRGLPR-432 2.19 5
p13 H3HA17 17-HHAVSNGTLVKTITNDQIEV-36 2.10 7
p14 H3HA97 97-CYPYDVPDYASLRSLVASSG-116 1.87 10
p15 H3HA297 297-VNRITYGACPRYVKQNTLKL-316 2.22 4
p16 H3HA305 305-CPRYVKQNTLKLATGMRNVP-324 2.27 3
p17 N2NA48 48-NQVMLCEPTIIERNITE-64 0.94 25
p18 N2NA96 96-GFAPFSKDNSIRLSAGG-112 1.35 16
p19 N2NA206 206-IYNGRLVDSIVSWSKEI-222 0.52 35
p20 N2NA236 236-TCTVVMTDGSASGKADT-252 0.48 36
p21 N2NA260 260-GKIVHTSTLSGSAQHVE-276 1.00 24
p22 N2NA390 390-LQINRQVIVDRGNRSGY-406 0.85 29
p23 N2NA402 402-NRSGYSGIFSVEGKSCI-418 0.93 26
p24 NP73 73-ERRNKYLEEHPSAGKDPKKT-92 1.42 15
p25 NP321 321-NP1HKSQLVWMACHSAAFED-340 0.73 31
p26 NP401 401-ASAGQISIQPTFSVQRNLPF-420 0.90 27
p27 NP433 433-TEGRTSDMRTEIIRMMESAR-452 0.84 30
p28 NP441 441-RTEIIRMMESARPEDVSFQG-460 0.65 32
p29 PB1/34 34-TGTGYTMDTVNRTHQ-48 2.17 6
p30 PB1/281 281-KLANVVRKMMTNSQDTE-297 1.43 14
p31 PB1/410 410-GMFNMLSTVLGVSILNLGQ-428 2.40 2
p32 MP9 9-TYVLSIVPSGPLKAEIAQRL-28 2.02 8
p33 MP57 57-KGILGFVFTLTVPSERGLQR-76 3.44 1
p34 MP73 73-GLQRRRFVQNALNGNGDPNN-92 1.15 22
p35 MP97 97-VKLYRKLKREITFHGAKEIA-116 1.84 11
p36 MP177 177-NRMVLASTTAKAMEQMAGSS-196 2.00 9
aThe average of 2log[p].
bbased on mean value of 2log[p].
doi:10.1371/journal.pone.0011355.t001
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study groups could be due to chance alone. For the autoimmune
diabetes study, interpreting the data in a discontinuous trait
fashion (using 95% confidence limit as a cutoff) seemed to be more
appropriate since the majority of responses were weak or null.
Based on this consideration, we concluded that there were no
detectable differences between any of these 10 epitope specific
CD4 T cells in peripheral blood of diabetic and non-diabetic
Table 2. Putative beta-cell autoantigenic peptides.
i.d Peptide Sequence References
1
aZnT8p28s 271-SILLMEGVPKSLN-283 [10] and unpublished data
2
bPPIp57 73-GAGSLQPLALEGSLQKRGIV-92 [9,11]
3
cIGRPp3 17-KDYRAYYTFLNFMSNVGDPR-36 [12]
4 IGRPp31 241-KWCANPDWIHIDTTPFAGLV-260 [12]
5
dGAD65p15 113-DVMNILLQYVVKSFDRSTKV-132 [13]
6 GAD65p35 273-LIAFTSEHSHFSLKKGAAAL-292 [13]
7 GAD65p70 553-KVNFFRMVISNPAATHQDID-572 [14]
8
eDMKp2 9-RLQQLVLDPGFLGLEPLLDL-28 unpublished data
9 DMKp23 177-AEIVMAIDSVHRLGYVHRDI-196 unpublished data
10
fIA4p46 953-VRSKDQFEFALTAVAEEVNA-972 [15]
aZinc transporter.
bPreproinsulin.
cIslet-specific gluose-6-phosphatase catalytic subunit-related protein.
dGlutamic Acid Decarboxylase 65.
eDystrophia Myotonica Kinase.
fIslet protein tyrosine phosphates.
doi:10.1371/journal.pone.0011355.t002
Table 3. Beta-cell epitope specific T cell responses.
Epitope Cytokine
aMean ± SD bP
cP (FDR.adj)
T1D (n=11) non-T1D (n=12)
ZnT8p28s IFNgamma 0.197360.1013 0.190060.1537 0.5524 0.7158
IL10 0.208260.1113 0.040060.03075 0.1423 0.3840
PPIp57 IFNgamma 0.442760.2308 0.441760.2633 0.9753 1.0000
IL10 0.313660.1326 0.191760.1351 0.4556 0.7158
IGRPp3 IFNgamma 0.613660.2161 0.300860.1619 0.1536 0.3840
IL10 0.113660.03681 *0.144560.1367 0.0845 0.3840
IGRPp31 IFNgamma 0.020060.01401 0.387560.2114 0.1221 0.3840
IL10 0.138260.08814 0.320060.1796 0.5494 0.7158
GAD65p15 IFNgamma 1.19360.4842 1.48260.6396 0.7345 0.8641
IL10 0.197360.1107 0.581760.1671 0.0777 0.3840
GAD65p35 IFNgamma 0.380060.1984 0.245060.1907 0.2534 0.5631
IL10 0.376460.1684 0.667560.2513 0.5140 0.7158
GAD65p70 IFNgamma 0.552760.2052 0.728360.4938 0.3684 0.7158
IL10 0.0490960.04157 0.448360.1609 0.0315 0.3840
DMKp2 IFNgamma 0.546460.1413 0.425060.2915 0.1290 0.3840
IL10 0.509160.1988 *0.989160.2402 0.1226 0.3840
DMKp23 IFNgamma 0.0690960.03781 0.255060.1820 0.8020 0.8911
IL10 0.070060.03057 0.281760.1288 0.5726 0.7158
IA2p46 IFNgamma 0.0554560.02745 0.110860.09193 0.5482 0.7158
IL10 0.179160.08849 0.133360.06713 1.0000 1.0000
aThe average of 2log[p].
bP was calculated by 2-tailed Mann-Whitney test.
cP was calculated with false discovery rate (FDR) adjustment using the Benjamini-Hochberg correction.
*only 11 non-T1D subjects were investigated.
doi:10.1371/journal.pone.0011355.t003
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that assessing T cell responses against these epitopes using the
cellular microarray did not provide a prediction of autoimmune
status or progression. Clearly, the low detection sensitivity of this
assay certainly contributed to the difficulty in detecting differences
in the T cell responses of diabetic and non-diabetic subjects. It is
also possible that the frequencies of self-reactive T cells might peak
near the time that disease is diagnosed and decrease afterwards so
that autoreactive T cells in long-term T1D patients (like those
recruited for this study) could decrease to levels that are only subtly
different from non-T1D subjects and difficult to distinguish
regardless of the assay used. In addition, the distribution of
autoreactive T cells in peripheral blood and other secondary
lymph organs such as pancreatic lymph nodes may not be
equivalent. Based on our results, conclude that further refinements
are needed to apply the cellular microarray to measure self-
reactive T cell responses in peripheral blood.
While progress has been made, there are still challenges for
cellular microarrays. First, the procedure for fabricating high
quality arrays is still technically difficult without sophisticated
equipment and high quality printing substrates. Second, unlike
DNA arrays, in which no secondary and/or tertiary structure is
required for a nuclear acid probe (immobilized on a solid surface)
to maintain its function and specificity, most proteins spotted on
the solid surface do no maintain their function over time. In fact,
the performance of cytokine capture antibodies from different
vendors varied dramatically even under the same fabrication
condition. Optimizing the stability of functional proteins is
essential to batch produce cellular microarrays that can provide
consistent results. A recent study using complementary DNA tags
as adaptors to immobilize peptide:MHC on the slides is innovative
[16]. Because the protein components are anchored on a slide
through various DNA adapters, changes of functional conforma-
tion due to direct physical adsorption are avoided. In addition,
since proteins are cross-linked to the immobilized cDNA just prior
to the assay, they are not required for the spotting procedure.
Therefore, this approach decreases the overall duration that
protein is exposed on the solid surface.
In summary, we herein describe fabrication and data interpre-
tation procedures for multiplex cellular microarray analysis of Ag-
specific T cels. Both the improvements over prior systems and
current technical limitations were discussed. The knowledge and
experience accumulated through two different applications
provided a guide for further refinement of the technology and
extending to other disease related translational studies.
Table 4. Beta-cell epitope specific T cell responses with 95% confidence correction (2log[p]$1.30).
IFNgamma IL10
T1D (n=11) Non-T1D (n=12) aP T1D (n=11) Non-T1D (n=12) aP
bPositive
cNegative
bPositive
cNegative
bPositive
cNegative
bPositive
cNegative
ZnT8p28s 0 11 1 11 1 0 11 0 12 1
PPIp57 29 21 01 11 021 0 1
*IGRPp3 1 10 1 11 1 0 11 1 10 1
IGRPp31 0 11 1 11 1 0 11 1 11 1
GAD65p15 3 8 3 9 1 0 11 2 10 0.4783
GAD65p35 1 10 1 11 1 1 10 3 9 0.5901
GAD65p70 29 11 10 . 5 9 01 111 1 1
*DMKp2 11 011 11 29 381
DMKp23 0 11 1 11 1 0 11 0 12 1
IA2p46 0 11 0 12 1 0 11 0 12 1
aP-value was calculated by 2-tailed Fisher Exact test.
b‘‘positive’’ was defined as a response with 2log[p]$1.30, which represents 95% confidence.
c‘‘negative’’ was defined as a response when 2log[p],1.30.
*only 11 non-T1D subjects were investigated.
doi:10.1371/journal.pone.0011355.t004
Figure 5. The counts of epitope specific IFNgamma (A) or IL10
(B) response for each individuals. Each circle represents a diabetic
(filled circle) or a non-diabetic subject (open circle). A Mann-Whitney
test was used for statistical calculation.
doi:10.1371/journal.pone.0011355.g005
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Vaccine, Peptides and antibodies
Fluzone seasonal influenza vaccine (2008–2009 formula) was
obtained from Aventis Pasteur (Swiftwater, PA). It contains
components of A/Brisbane/59/2007 (H1N1), A/Uruguay/716/
2007 (H3N2) and B/Florida/04/2006. In addition to HA and NA,
the presence of internal antigens NP, M1MP and PB1 was
adequately demonstrated in one of our previous studies [21]. After
extensive dialysis to remove nonionic surfactant and preservative,
the vaccine was diluted into 1xPBS with protein concentration
adjusted to 500 ug/ml. Peptides were purchased from Sigma (St.
Louis, MO) or Mimotope (Clayton Victoria, Australia). Functional
grade anti-CD28 and anti-CD11a was purchased from
eBioscience (San Diego, CA) and Leinco (St. Louis, MO),
respectively. For microarray preparation, anti-IFNgamma capture
and biotin-labeled detection antibodies were obtained from Pierce
(Rockford, IL). Anti-IL10 capture and biotin-labeled detection
antibodies were purchased from BD Bioscience (San Diego, CA).
IFNgamma ELISA antibody pairs were purchased from
eBioscience. Cy3- and Cy5-conjugated donkey anti-mouse IgG,
anti-Rat IgG antibodies were purchase from Jackson ImmunoR-
esearch Laboratories (West Grove, PA). AlexFluor555- and
AlexFluor647-conjugated streptavidin were obtained from Invi-
trogen (Carlsbad, CA).
Subjects
For studying Influenza A specific T cell responses, HLA-
DR0401
+ donors (n=12) were recruited between June and
October 2009. For the diabetes related self-antigen specific T cell
study, samples (n=23) were obtained from both frozen PBMCs
and freshly collected peripheral blood from donors recruited
between October 2008 and June 2009. The studies were approved
by the Institutional Review Board of Benaroya Research Institute
(BRI, Seattle, WA). HLA typing was conducted by BRI
sequencing and genotyping core facilities. All DR0401
+ subjects
were volunteers of Caucasian descent and were recruited with
written consent for these studies.
Expression, purification of recombinant HLA-DR0401 and
Tetramer preparation
Recombinant HLA-DR0401 was expressed by stable transfect-
ed S2 cells and purified by affinity chromatography as previously
described [1]. To prepare these reagents for arrays, non-
biotinylated DR0401 was loaded with candidate peptide in
pH6.0 phosphate buffer in the presence of 2.5 mg/ml of n-
Octyl-D-glucopyranoside (Sigma) and protease inhibitors at 37uC
for 72 hours. Peptide:DR4 was thoroughly exchanged into pH7.0
1xPBS using Microcon YM-10 (Millipore, Billerica, MA).
Unbound peptide and n-Octyl-D-glucopyranoside were also
removed during the dialysis. For tetramer, the purified DR0401
was biotinylated according to manufacturer’s instruction (Avidity,
Aurora, CO). Peptide was loaded as described above and
conjugated with PE-streptavidin (Invitrogen).
Preparation of peptide:MHC Class II cellular arrays
The spotting cocktails contained 100 ug/ml peptide:DR0401,
200 ug/ml cytokine capture antibody, 50 ug/ml anti-CD28 and
50 ug/ml anti-CD11a in pH7.0 1xPBS. The reagents were loaded
into a 384-well polypropylene plate and dispensed onto CCL2
chamber slides (FisherScientific, Pittsburgh, PA) with RoboAr-
rayer (BioRad, Hercules, CA) in contact spotting fashion using one
single 946MP15XB stealth pin (ArrayIt, Sunnyvale, CA) under
24uC, 60% humidity chamber. The pin dispensed 8–10 replicates
for every load of reagent. The pin was rinsed with sonication and
dried extensively between sample switching. Slides were stored in a
desiccator at 4uC until use.
Peptide:MHC cellular microarray assaying
Slides were blocked by 2% normal donkey serum (Jackson
ImmunoResearch) for 20 minutes at 4uC and rinsed gently by cold
1xPBS. Cultured CD4 T cells (3610
6 cells/chamber for 2-
chamber slides or 6610
6 cells/chamber for 1-chamber slides) were
loaded onto peptide:MHC microarray and incubated at a well-
leveled 37uC5 %C O 2 incubator for 6 hours. After incubation, the
slides were sequentially washed by 2 cycles of 1xPBS, 2 cycles of
H2O (5 minutes/cycle to ensure the disruption of the cell) and 2
cycles of washing buffer (1 minute/cycle) containing 1xPBS,
0.02% Tween-20. Slides were then incubated with 1:250 diluted
biotin-labeled detection antibodies at room temperature for
1 hour. Following two cycles of washing, the slides were probed
with 1:1000 diluted AlexFluor555-streptavidin and Cy5-anti-
mouse-IgG (or anti-Rat-IgG) for 1 hour at room temperature in
the dark then rinsed with washing buffer twice and H2O once.
Filtered, compressed air was used to remove any liquid remaining
on the slides prior to image acquisition.
Data acquisition, processing and interpretation
Slides were scanned using a Typhoon 9410 Variable Mode
Imager (GE Healthcare) under fluorescence acquisition mode.
For Cy3- or AlexFluor555 probes, a 532 nm excitation laser
source and 580BP30 emission filter were chosen while PMT
voltage was set at 750. For Cy5- or AlexFluor647 probes, a
633 nm excitation laser source and 670BP30 emission filter
were chosen while the PMT voltage was set at 600. For scan
resolution, pixel size was set as 50 mm. The image was initially
analyzed using ImageQuant TL v7.0 (GE Healthcare) under
Array Analysis section for absolute fluorescence intensity (AFI)
measurement. The electronic noise signals (size ,3) were
filtered. For each slide, the image from a reference channel
(probed by Cy5-conjugated anti-mouse and/or anti-Rat IgG)
was used to set a grid that positioned the location of individual
spot. Manual adjustment was required occasionally. After the
grid was properly positioned, image was switched to the sample
channel (probed by AlexFluor555-conjugated streptavidin) and
fluorescence readings for each spot were recorded. The raw
data was exported into MS-Excel for storage and further
analysis using the program further described in Result
section).
Microscopy and cell counting
After 6 hours of incubation, with the chamber still at mounted
position, the slides were gently washed by 1xPBS and observed by
using a Leica DM-IRM inverted microscope. Images of individual
spots were obtained by using a SPOT RT camera with SPOT-
Advance software (Diagnostic Instruments, Serling Heights, MI).
The cell number for individuals spots were counted by using
ImageQuant TL software under Colony Counting sector.
Ag-specific CD4 T cell line generation and maintenance
CD4 T cell lines specific to Influenza A Hemagglutinin (HA306:
PKYVKQNTLKLAT), Neuraminidase (NAp43: GAASYKIF-
KIEKGKVTK) and Islet-Specific Glucose-6-Phosphatase Cata-
lytic Subunit-Related Protein (IGRPp31: KWCANPDWI-
HIDTTPFAGLV) were generated by cell sorting based on
positive tetramer staining of T cells from a day-14 in vitro peptide
stimulated T cell culture. The sorted T cells were maintained in
Functional T Cell Microarray
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weekly in the presence of 50 Gy irradiated allogenetic PBMCs and
10 IU/ml of IL2. The purity of the Ag-specific T cells was
determined by tetramer staining.
In vitro T cell stimulation
CD4 T cells were purified and stimulated with candidate
peptides or viral antigens prepare from vaccine for one week and
expanded with recombinant IL2 for another week as previously
described [12,21].
Cytokine production and ELISA
A flat-bottom 96-well plate was coated with a mixture of 10 ug/
ml peptide:DR0401 monomer, 5 ug/ml anti-CD28 and 5 ug/ml
anti-CD11a overnight at 4uC. On the next day, the plate was
washed once with 1xPBS and seeded with 100610
3,5 0 610
3,
20610
3 and 5610
3 of T cells, respectively. After a brief centrifuge
spin to settle down cells, the plate was incubated at 37uC for
6 hours. The concentration of IFNgamma in the supernatant was
determined by ELISA using Europium detection system (Perkin
Elmer, Waltham, MA).
Statistical analysis
The coefficient of variation for spotting was estimated using
Prism software (GraphPad, San Diego, CA). Differences in Ag-
specific T cell responses between T1D and non-diabetic subjects
were evaluated with Mann-Whitney test (provided by Prism
software) and Fisher’s Exact Test (www.langsrud.com/fisher.htm)
as 2-tailed p-values. The Benjamini-Hochberg correction was
adapted to calculate p-values with false discovery rate (FDR)
adjustment.
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